Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 534

1.

Performance of propensity score matching to estimate causal effects in small samples.

Andrillon A, Pirracchio R, Chevret S.

Stat Methods Med Res. 2020 Mar;29(3):644-658. doi: 10.1177/0962280219887196. No abstract available.

PMID:
32186264
2.

[Satisfaction survey in the clinical investigations center (CIC-1427) in Saint-Louis hospital Paris, France].

Dupont A, Chevret S, Montlahuc C, Resche-Rigon M, Fontaine Y, Allaoua S, Kiladjian JJ, Ghrieb Z.

Therapie. 2020 Feb 8. pii: S0040-5957(20)30006-8. doi: 10.1016/j.therap.2020.02.001. [Epub ahead of print] French. No abstract available.

PMID:
32113690
3.

Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department.

Peyrony O, Gerlier C, Barla I, Ellouze S, Legay L, Azoulay E, Chevret S, Fontaine JP.

PLoS One. 2020 Feb 28;15(2):e0229828. doi: 10.1371/journal.pone.0229828. eCollection 2020.

4.

A prospective phase II of daratumumab in previously treated systemic light chain amyloidosis (AL) patients.

Roussel M, Merlini G, Chevret S, Arnulf B, Stoppa AM, Perrot A, Palladini G, Karlin L, Royer B, Huart A, Macro M, Morel P, Frenzel L, Touzeau C, Boyle EM, Dorvaux V, Le Bras F, Lavergne D, Bridoux F, Jaccard A.

Blood. 2020 Feb 27. pii: blood.2019004369. doi: 10.1182/blood.2019004369. [Epub ahead of print]

PMID:
32108228
5.

Thiamine status and lactate concentration in sepsis: A prospective observational study.

Heming N, Salah A, Meng P, Sivanandamoorthy S, Bounab R, Chevret S, Annane D.

Medicine (Baltimore). 2020 Feb;99(7):e18894. doi: 10.1097/MD.0000000000018894.

6.

Lymphomas with kidney involvement: the French multicenter retrospective LyKID study.

Kohn M, Karras A, Zaidan M, Bénière C, de Fréminville JB, Laribi K, Perrin MC, Malphettes M, Le Calloch R, Anglaret B, Martiniuc J, Bailly S, Chevret S, Molina T, Thervet E, Thieblemont C.

Leuk Lymphoma. 2020 Apr;61(4):887-895. doi: 10.1080/10428194.2019.1697811. Epub 2020 Feb 10.

PMID:
32037948
7.

Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites.

Michonneau D, Latis E, Curis E, Dubouchet L, Ramamoorthy S, Ingram B, de Latour RP, Robin M, de Fontbrune FS, Chevret S, Rogge L, Socié G.

Nat Commun. 2019 Dec 13;10(1):5695. doi: 10.1038/s41467-019-13498-3.

8.

Acute hypoxaemic respiratory failure in immunocompromised patients: abandon bronchoscopy or make it better?

Bauer PR, Chevret S, Azoulay E; Nine-I Investigators.

Eur Respir J. 2019 Dec 12;54(6). pii: 1902177. doi: 10.1183/13993003.02177-2019. Print 2019 Dec. No abstract available.

PMID:
31831677
9.

Genetic landscape of adult Langerhans cell histiocytosis with lung involvement.

Jouenne F, Chevret S, Bugnet E, Clappier E, Lorillon G, Meignin V, Sadoux A, Cohen S, Haziot A, How-Kit A, Kannengiesser C, Lebbé C, Gossot D, Mourah S, Tazi A.

Eur Respir J. 2020 Feb 27;55(2). pii: 1901190. doi: 10.1183/13993003.01190-2019. Print 2020 Feb.

PMID:
31806714
10.

Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial.

Peffault de Latour R, Chevret S, Ruggeri AL, Suarez F, Souchet L, Michonneau D, Sicre de Fontbrune F, Coman T, Dhedin N, Rubio MT, Nguyen S, Mohty M, Socié G.

Blood. 2020 Jan 16;135(3):227-229. doi: 10.1182/blood.2019000358. No abstract available.

PMID:
31805185
11.

Prevention of Pathological Fracture of the Proximal Femur: A Systematic Review of Surgical and Percutaneous Image-Guided Techniques Used in Interventional Oncology.

Rodrigues L, Cornelis FH, Reina N, Chevret S.

Medicina (Kaunas). 2019 Nov 22;55(12). pii: E755. doi: 10.3390/medicina55120755. Review.

12.

Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.

Cheng GS, Bondeelle L, Gooley T, He Q, Jamani K, Krakow EF, Flowers MED, de Latour RP, Michonneau D, Socié G, Chien JW, Chevret S, Bergeron A.

Biol Blood Marrow Transplant. 2020 Feb;26(2):392-400. doi: 10.1016/j.bbmt.2019.10.025. Epub 2019 Nov 1.

PMID:
31682980
13.

Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis.

Le Guen P, Chevret S, Bugnet E, de Margerie-Mellon C, Lorillon G, Seguin-Givelet A, Jouenne F, Gossot D, Vassallo R, Tazi A.

Orphanet J Rare Dis. 2019 Oct 21;14(1):229. doi: 10.1186/s13023-019-1203-5.

14.

Baseline MRI inflammation is not a determinant of 5-year bone mineral density loss in patients with early spondyloarthritis.

Fechtenbaum M, Molto A, Roux C, Goupille P, Chevret S, Briot K.

Joint Bone Spine. 2020 Jan;87(1):63-68. doi: 10.1016/j.jbspin.2019.09.016. Epub 2019 Oct 11.

PMID:
31606496
15.

Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study.

Salvadori N, Decker L, Ngo-Giang-Huong N, Mary JY, Chevret S, Arunothong S, Adam P, Khamduang W, Samleerat T, Luangsook P, Suksa-Ardphasu V, Achalapong J, Rouzioux C, Sirirungsi W, Jourdain G.

AIDS Behav. 2019 Oct 11. doi: 10.1007/s10461-019-02695-2. [Epub ahead of print]

PMID:
31605294
16.

Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients.

Peyrony O, Chevret S, Meert AP, Perez P, Kouatchet A, Pène F, Mokart D, Lemiale V, Demoule A, Nyunga M, Bruneel F, Lebert C, Benoit D, Mirouse A, Azoulay E.

Ann Intensive Care. 2019 Oct 2;9(1):110. doi: 10.1186/s13613-019-0587-7.

17.

Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis.

Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A.

Rheumatology (Oxford). 2019 Sep 14. pii: kez385. doi: 10.1093/rheumatology/kez385. [Epub ahead of print]

PMID:
31529073
18.

Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failure.

Dumas G, Demoule A, Mokart D, Lemiale V, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Stoclin A, Louis G, Constantin JM, Wallet F, Kouatchet A, Peigne V, Perez P, Girault C, Jaber S, Cohen Y, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Benoit D, Darmon M, Chevret S, Azoulay E.

Crit Care. 2019 Sep 6;23(1):306. doi: 10.1186/s13054-019-2590-7.

19.

Association between early advanced life support and good neurological outcome in out of hospital cardiac arrest: A propensity score analysis.

Michelland L, Adnet F, Escutnaire J, Baker C, Hubert H, Chevret S.

J Eval Clin Pract. 2019 Aug 29. doi: 10.1111/jep.13268. [Epub ahead of print]

PMID:
31466139
20.

ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials.

Grafféo N, Latouche A, Le Tourneau C, Chevret S.

Comput Biol Med. 2019 Aug;111:103339. doi: 10.1016/j.compbiomed.2019.103339. Epub 2019 Jun 24.

PMID:
31442762
21.

Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study.

Jachiet M, Nosbaum A, Staumont-Sallé D, Seneschal J, Viguier M, Soria A, Barbaud A, Carriou AC, Chuffart-Delplanque M, Darrigade AS, Fite C, de Masson A, Bagot M, Chevret S, Bouaziz JD; French Group of Research and Study in Atopic Dermatitis (GREAT) from the French Society of Dermatology (SFD).

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e451-e453. doi: 10.1111/jdv.15774. Epub 2019 Jul 22. No abstract available.

PMID:
31273834
22.

High cutoff haemodialysis in myeloma cast nephropathy: further investigation is needed.

Bridoux F, Chevret S, Fermand JP.

Lancet Haematol. 2019 Jul;6(7):e347. doi: 10.1016/S2352-3026(19)30090-0. No abstract available.

PMID:
31244474
23.

Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.

Hervé D, Ibos-Augé N, Calvière L, Rogan C, Labeyrie MA, Guichard JP, Godin O, Kossorotoff M, Habert MO, Lasserve ET, Chevret S, Chabriat H.

Neurology. 2019 Jul 23;93(4):e388-e397. doi: 10.1212/WNL.0000000000007819. Epub 2019 Jun 25.

24.

Mottling score is a strong predictor of 14-day mortality in septic patients whatever vasopressor doses and other tissue perfusion parameters.

Dumas G, Lavillegrand JR, Joffre J, Bigé N, de-Moura EB, Baudel JL, Chevret S, Guidet B, Maury E, Amorim F, Ait-Oufella H.

Crit Care. 2019 Jun 10;23(1):211. doi: 10.1186/s13054-019-2496-4.

25.

Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort.

Schmidt M, Pham T, Arcadipane A, Agerstrand C, Ohshimo S, Pellegrino V, Vuylsteke A, Guervilly C, McGuinness S, Pierard S, Breeding J, Stewart C, Ching SSW, Camuso JM, Stephens RS, King B, Herr D, Schultz MJ, Neuville M, Zogheib E, Mira JP, Rozé H, Pierrot M, Tobin A, Hodgson C, Chevret S, Brodie D, Combes A.

Am J Respir Crit Care Med. 2019 Oct 15;200(8):1002-1012. doi: 10.1164/rccm.201806-1094OC.

PMID:
31144997
26.

Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy.

Bauer PR, Chevret S, Yadav H, Mehta S, Pickkers P, Bukan RB, Rello J, van de Louw A, Klouche K, Meert AP, Martin-Loeches I, Marsh B, Socias Crespi L, Moreno-Gonzalez G, Buchtele N, Amrein K, Balik M, Antonelli M, Nyunga M, Barratt-Due A, Bergmans DCJJ, Spoelstra-de Man AME, Kuitunen A, Wallet F, Seguin A, Metaxa V, Lemiale V, Burghi G, Demoule A, Karvunidis T, Cotoia A, Klepstad P, Møller AM, Mokart D, Azoulay E; Efraim investigators and the Nine-I study group.

Eur Respir J. 2019 Jul 25;54(1). pii: 1802442. doi: 10.1183/13993003.02442-2018. Print 2019 Jul.

PMID:
31109985
27.

High-Flow Oxygen Therapy for Respiratory Failure in Immunocompromised Patients-Reply.

Azoulay E, Chevret S, Demoule A.

JAMA. 2019 May 14;321(18):1827. doi: 10.1001/jama.2019.2064. No abstract available.

PMID:
31087018
28.

Influenza and associated co-infections in critically ill immunosuppressed patients.

Martin-Loeches I, Lemiale V, Geoghegan P, McMahon MA, Pickkers P, Soares M, Perner A, Meyhoff TS, Bukan RB, Rello J, Bauer PR, van de Louw A, Taccone FS, Salluh J, Hemelaar P, Schellongowski P, Rusinova K, Terzi N, Mehta S, Antonelli M, Kouatchet A, Klepstad P, Valkonen M, Landburg PP, Barratt-Due A, Bruneel F, Pène F, Metaxa V, Moreau AS, Souppart V, Burghi G, Girault C, Silva UVA, Montini L, Barbier F, Nielsen LB, Gaborit B, Mokart D, Chevret S, Azoulay E; Efraim investigators and the Nine-I study group.

Crit Care. 2019 May 2;23(1):152. doi: 10.1186/s13054-019-2425-6.

29.

Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.

Ouedraogo E, Gottlieb J, de Masson A, Lepelletier C, Jachiet M, Salle de Chou C, Galicier L, Bagot M, Chevret S, Bouaziz JD.

J Am Acad Dermatol. 2019 Jun;80(6):1544-1549. doi: 10.1016/j.jaad.2018.03.043. Epub 2019 Apr 10.

PMID:
30981429
30.

Risk of severe maternal morbidity associated with cesarean delivery and the role of maternal age: a population-based propensity score analysis.

Korb D, Goffinet F, Seco A, Chevret S, Deneux-Tharaux C; EPIMOMS Study Group.

CMAJ. 2019 Apr 1;191(13):E352-E360. doi: 10.1503/cmaj.181067.

31.

Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.

Peyrony O, Tieghem Y, Franchitti J, Ellouze S, Morra I, Madelaine-Chambrin I, Flicoteaux R, Baroudjian B, Azoulay E, Chevret S, Fontaine JP.

Emerg Med J. 2019 May;36(5):306-309. doi: 10.1136/emermed-2018-208091. Epub 2019 Mar 25.

PMID:
30910911
32.

Center Effects in Hospital Mortality of Critically Ill Patients With Hematologic Malignancies.

Biard L, Darmon M, Lemiale V, Mokart D, Chevret S, Azoulay E, Resche-Rigon M.

Crit Care Med. 2019 Jun;47(6):809-816. doi: 10.1097/CCM.0000000000003717.

PMID:
30889024
33.

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.

Sébert M, Renneville A, Bally C, Peterlin P, Beyne-Rauzy O, Legros L, Gourin MP, Sanhes L, Wattel E, Gyan E, Park S, Stamatoullas A, Banos A, Laribi K, Jueliger S, Bevan L, Chermat F, Sapena R, Nibourel O, Chaffaut C, Chevret S, Preudhomme C, Adès L, Fenaux P; Groupe Francophone des Myélodysplasies (GFM).

Haematologica. 2019 Aug;104(8):1565-1571. doi: 10.3324/haematol.2018.207118. Epub 2019 Feb 7.

34.

Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.

Bernaudin F, Verlhac S, Peffault de Latour R, Dalle JH, Brousse V, Petras E, Thuret I, Paillard C, Neven B, Galambrun C, Divialle-Doumdo L, Pondarré C, Guitton C, Missud F, Runel C, Jubert C, Elana G, Ducros-Miralles E, Drain E, Taïeb O, Arnaud C, Kamdem A, Malric A, Elmaleh-Bergès M, Vasile M, Leveillé E, Socié G, Chevret S; DREPAGREFFE Trial Investigators.

JAMA. 2019 Jan 22;321(3):266-276. doi: 10.1001/jama.2018.20059.

35.

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis.

Robin M, Chevret S, Koster L, Wolschke C, Yakoub-Agha I, Bourhis JH, Chevallier P, Cornelissen JJ, Reményi P, Maertens J, Poiré X, Craddock C, Socié G, Itälä-Remes M, Schouten HC, Marchand T, Passweg J, Blaise D, Damaj G, Ozkurt ZN, Zuckerman T, Cluzeau T, Labussière-Wallet H, Cammenga J, McLornan D, Chalandon Y, Kröger N.

Haematologica. 2019 Jun;104(6):1230-1236. doi: 10.3324/haematol.2018.201400. Epub 2019 Jan 17.

36.

Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.

Blandinières A, Gendron N, Bacha N, Bièche I, Chocron R, Nunes H, Nevo N, Rossi E, Crestani B, Lecourt S, Chevret S, Lokajczyk A, Mignon V, Kisaoglu A, Juvin K, Bertil S, Valeyre D, Cras A, Gaussem P, Israël-Biet D, Smadja DM.

Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.

PMID:
30607696
37.
38.

Echographic Assessment of Diaphragmatic Function in Duchenne Muscular Dystrophy from Childhood to Adulthood.

Fayssoil A, Chaffaut C, Ogna A, Stojkovic T, Lamothe L, Mompoint D, Meng P, Prigent H, Clair B, Behin A, Laforet P, Bassez G, Carlier R, Orlikowski D, Amthor H, Quijano Roy S, Crenn P, Chevret S, Eymard B, Lofaso F, Annane D.

J Neuromuscul Dis. 2019;6(1):55-64. doi: 10.3233/JND-180326.

PMID:
30562904
39.

Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial.

Geoffroy PA, Abbassi EMBE, Maruani J, Etain B, Lejoyeux M, Amad A, Courtet P, Dubertret C, Gorwood P, Vaiva G, Bellivier F, Chevret S.

Psychiatry Investig. 2018 Dec;15(12):1188-1202. doi: 10.30773/pi.2018.09.27.1. Epub 2018 Nov 26.

40.

Intensive care medicine in 2050: clinical trials designs.

Gasparini M, Chevret S.

Intensive Care Med. 2019 May;45(5):668-670. doi: 10.1007/s00134-018-5364-9. Epub 2018 Nov 14. No abstract available.

PMID:
30430206
41.

Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study.

Lê MP, Chaix ML, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS-165 DARULIGHT study group.

Br J Clin Pharmacol. 2019 Jan;85(1):277-280. doi: 10.1111/bcp.13796. Epub 2018 Nov 12. No abstract available.

42.

A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM).

Ades L, Guerci-Bresler A, Cony-Makhoul P, Legros L, Sebert M, Braun T, Delaunay J, Desseaux K, Chevret S, Fenaux P.

Haematologica. 2019 Apr;104(4):e131-e133. doi: 10.3324/haematol.2018.203885. Epub 2018 Oct 31. No abstract available.

43.

Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.

Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Berrahil-Meksen L, Louis G, Constantin JM, Mayaux J, Wallet F, Kouatchet A, Peigne V, Théodose I, Perez P, Girault C, Jaber S, Oziel J, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Darmon M, Chevret S, Demoule A.

JAMA. 2018 Nov 27;320(20):2099-2107. doi: 10.1001/jama.2018.14282.

44.

Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure.

Dumas G, Chevret S, Lemiale V, Pène F, Demoule A, Mayaux J, Kouatchet A, Nyunga M, Perez P, Argaud L, Barbier F, Vincent F, Bruneel F, Klouche K, Kontar L, Moreau AS, Reignier J, Papazian L, Cohen Y, Mokart D, Azoulay E.

Oncotarget. 2018 Sep 14;9(72):33682-33693. doi: 10.18632/oncotarget.26069. eCollection 2018 Sep 14.

45.

Morbidity and Mortality of Crystalloids Compared to Colloids in Critically Ill Surgical Patients: A Subgroup Analysis of a Randomized Trial.

Heming N, Lamothe L, Jaber S, Trouillet JL, Martin C, Chevret S, Annane D.

Anesthesiology. 2018 Dec;129(6):1149-1158. doi: 10.1097/ALN.0000000000002413.

46.

Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group.

Roos-Weil D, Nguyen-Khac F, Chevret S, Touzeau C, Roux C, Lejeune J, Cosson A, Mathis S, Feugier P, Leprêtre S, Béné MC, Baron M, Raynaud S, Struski S, Eclache V, Sutton L, Lesty C, Merle-Béral H, Cymbalista F, Ysebaert L, Davi F, Leblond V; FILO working group.

Genes Chromosomes Cancer. 2018 Nov;57(11):533-540. doi: 10.1002/gcc.22650. Epub 2018 Sep 11.

47.

Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors.

Galimard JE, Chevret S, Curis E, Resche-Rigon M.

BMC Med Res Methodol. 2018 Aug 31;18(1):90. doi: 10.1186/s12874-018-0547-1.

48.

Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy.

Laredo M, Khraiche D, Raisky O, Gaudin R, Bajolle F, Maltret A, Chevret S, Bonnet D, Vouhé PR.

J Thorac Cardiovasc Surg. 2018 Dec;156(6):2285-2294.e2. doi: 10.1016/j.jtcvs.2018.06.040. Epub 2018 Jul 18.

PMID:
30104063
49.

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.

Ganne-Carrié N, Chaffaut C, Bourcier V, Archambeaud I, Perarnau JM, Oberti F, Roulot D, Moreno C, Louvet A, Dao T, Moirand R, Goria O, Nguyen-Khac E, Carbonell N, Antonini T, Pol S, de Ledinghen V, Ozenne V, Henrion J, Péron JM, Tran A, Perlemuter G, Amiot X, Zarski JP, Beaugrand M, Chevret S; for CIRRAL Group.

J Hepatol. 2018 Dec;69(6):1274-1283. doi: 10.1016/j.jhep.2018.07.022. Epub 2018 Aug 6.

50.

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.

Lambert J, Pautas C, Terré C, Raffoux E, Turlure P, Caillot D, Legrand O, Thomas X, Gardin C, Gogat-Marchant K, Rubin SD, Benner RJ, Bousset P, Preudhomme C, Chevret S, Dombret H, Castaigne S.

Haematologica. 2019 Jan;104(1):113-119. doi: 10.3324/haematol.2018.188888. Epub 2018 Aug 3.

Supplemental Content

Loading ...
Support Center